Compass Pathways presents COMP360 psilocybin research at NEI Fall Congress
CMPS•Compass Pathways will present COMP360 psilocybin research at the Neuroscience Education Institute Fall Congress in Colorado Springs, Nov. 5-8, 2026, including findings from two Phase 3 trials in treatment-resistant depression.
1. Congress presentations
Compass Pathways will attend the Neuroscience Education Institute Fall Congress in Colorado Springs, Colorado, Nov. 5-8, 2026. Presentations on COMP360 psilocybin will cover safety, efficacy and participant characteristics from two Phase 3 trials in treatment-resistant depression. A Change the Tune in TRD educational panel for US healthcare professionals is scheduled for Nov. 8 from 7 to 8 a.m.
